# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010790
Filing Date
2025-05-15
Accepted
2025-05-15 15:35:22
Documents
66
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 943012
2 | EX-4.6 | ex4-6.htm | EX-4.6 | 96387
3 | EX-10.2 | ex10-2.htm | EX-10.2 | 342232
4 | EX-31.1 | ex31-1.htm | EX-31.1 | 21489
5 | EX-31.2 | ex31-2.htm | EX-31.2 | 20919
6 | EX-32.1 | ex32-1.htm | EX-32.1 | 7116
7 | EX-32.2 | ex32-2.htm | EX-32.2 | 6551
8 | GRAPHIC | form10-q_001.jpg | GRAPHIC | 130597
9 | GRAPHIC | form10-q_002.jpg | GRAPHIC | 232087
10 | GRAPHIC | form10-q_003.jpg | GRAPHIC | 59541
11 | GRAPHIC | form10-q_004.jpg | GRAPHIC | 70010
12 | GRAPHIC | form10-q_005.jpg | GRAPHIC | 54607
13 | GRAPHIC | form10-q_006.jpg | GRAPHIC | 45007
| Complete submission text file | 0001641172-25-010790.txt |  | 7106672

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL SCHEMA FILE | gtbp-20250331.xsd | EX-101.SCH | 38979
15 | XBRL CALCULATION FILE | gtbp-20250331_cal.xml | EX-101.CAL | 32260
16 | XBRL DEFINITION FILE | gtbp-20250331_def.xml | EX-101.DEF | 166929
17 | XBRL LABEL FILE | gtbp-20250331_lab.xml | EX-101.LAB | 305622
18 | XBRL PRESENTATION FILE | gtbp-20250331_pre.xml | EX-101.PRE | 246678
68 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 778804

Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 25952007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)